Drug reps will promote Avandia (rosiglitazone) as more effective than metformin for initial therapy of type 2 diabetes

Drug reps will promote Avandia (rosiglitazone) as more effective than metformin for initial therapy of type 2 diabetes.

They're citing a new study that suggests patients maintain control longer with rosiglitazone than with metformin or glyburide.

You'll hear that 5-year treatment failures are 32% higher with metformin and 63% higher with glyburide compared to rosiglitazone.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote